Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Signature Expands the Landscape of Driver Negative Thyroid Cancers

15 Oct 2021

Abstract excerpt

Thyroid cancer is the most common endocrine malignancy. However, the cytological diagnosis of follicular thyroid carcinoma (FTC), Hürthle cell carcinoma (HCC), and follicular variant of papillary thyroid carcinoma (FVPTC) and their benign counterparts is a challenge for preoperative diagnosis. Nearly 20–30% of biopsied thyroid nodules are classified as having indeterminate risk of malignancy and incur costs to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Ferroptosis and cancer prognosis
Share to Thyroid Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34680332
DOI: 10.3390/cancers13205184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Signature Expands the Landscape of Driver Negative Thyroid CancersPMID 34680332Read ↗

Molecular findings in thyroid tumors: Practical diagnostic, prognostic, and therapeutic insights.Semantic proximity Read ↗

The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy.Semantic proximity Read ↗

Genomic alterations in thyroid cancer: biological and clinical insights.Semantic proximity Read ↗

Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend the Latest WHO ClassificationSemantic proximity Read ↗

Molecular Markers Guiding Thyroid Cancer ManagementSemantic proximity Read ↗

Identification of Novel Oncogenic Mutations in Thyroid Cancer.Semantic proximity Read ↗

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.Semantic proximity Read ↗

Molecular Markers in Follicular and Oncocytic Thyroid Carcinomas: Clinical Application of Molecular Genetic TestingSemantic proximity Read ↗

An integrated analysis of cancer genes in thyroid cancer.Semantic proximity Read ↗

SEAP-GETNE consensus on prognostic and predictive molecular biomarkers in thyroid cancer.Semantic proximity Read ↗

Update on Molecular Diagnostics in Thyroid Pathology: A ReviewSemantic proximity Read ↗

Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.